How applicable is the single-dose AMBITION regimen for HIV-associated cryptococcal meningitis to high-income settings?
29 Sep, 2022 | 13:26h | UTC
Commentary on Twitter
How applicable is the single-dose liposomal amphotericin B (AMBITION regimen) for HIV-associated cryptococcal meningitis to high-income settings?
Very, argue leaders of the @ambitioncm2020 trial in @CIDJournal https://t.co/eUlWG0t1Xv pic.twitter.com/8JGBU1oWeO
— Ilan Schwartz MD PhD (@GermHunterMD) September 27, 2022
Under a https://creativecommons.org/licenses/by/4.0/ license